Registry for patients with metastatic spine tumors
Metastatic Tumor Research and Outcome Network A Multicenter Prospective Registry for the Management and Outcome of Metastatic Spine Tumors
This study is collecting information from patients with metastatic spine tumors to see how different factors affect their health and treatment outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 960 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | AO Innovation Translation Center Academic / other |
| Locations | 25 sites (San Francisco, California and 24 other locations) |
| Trial ID | NCT02830451 on ClinicalTrials.gov |
What this trial studies
This registry collects comprehensive data on patients diagnosed with metastatic spine tumors, including demographics, treatment history, and clinical outcomes. It aims to identify prognostic variables that influence patient-reported outcomes, morbidity, local tumor control, and overall survival. By gathering detailed information on symptoms, imaging, and treatment details, the registry seeks to enhance understanding of the disease and improve patient care.
Who should consider this trial
Good fit: Ideal candidates for this registry are adults aged 18 and older who have been diagnosed with a metastatic tumor of the spine.
Not a fit: Patients with primary tumors of the spine will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment strategies and better quality of life for patients with metastatic spine tumors.
How similar studies have performed: Other studies focusing on registries for metastatic cancers have shown success in improving patient outcomes and understanding disease progression.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient 18 or older. * Patient diagnosed with a metastatic tumor of the spine * Informed consent obtained, i.e.: * Ability to understand the content of the patient information/ICF * Willingness and ability to participate in the registry according to the Registry Plan * Signed and dated EC/IRB approved written informed consent (if consent is required by the EC/ IRB at the registry site) Exclusion Criteria: • Patient diagnosed with a primary tumor of the spine.
Where this trial is running
San Francisco, California and 24 other locations
- University of California The UCSF Spine Center Department of Neurological Surgery — San Francisco, California, United States (Recruiting)
- Rush University Medical Center University Neurosurgery — Chicago, Illinois, United States (Recruiting)
- Johns Hopkins University Department of Neurosurgery / Spine Division — Baltimore, Maryland, United States (Recruiting)
- Harvard Medical School Department of Neurosurgery — Boston, Massachusetts, United States (Recruiting)
- Mayo Clinic Department of Neurosurgery — Rochester, Minnesota, United States (Recruiting)
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States (Recruiting)
- University of Rochester School of Medicine and Dentistry Department of Orthopaedic Surgery and Neurosurgery — Rochester, New York, United States (Recruiting)
- Westchester Medical Center Department of Neurosurgery — Valhalla, New York, United States (Not_yet_recruiting)
- Penn Presbyterian Medical Center Department of Neurosurgery — Philadelphia, Pennsylvania, United States (Recruiting)
- The Warren Alpert Medical School of Brown university Department of Neurosurgery — Providence, Rhode Island, United States (Recruiting)
- The University of Texas MD Anderson Cancer Center Department of Neurosurgery — Houston, Texas, United States (Recruiting)
- Monash University Melbourne — Clayton, Victoria, Australia (Recruiting)
- Vancouver General Hospital and the University of British Columbia — Vancouver, British Columbia, Canada (Recruiting)
- Winnipeg Spine Program University of Manitoba Department of Surgery — Winnipeg, Manitoba, Canada (Recruiting)
- Toronto Western Hospital Department of Neurosurgery Division of Surgery — Toronto, Ontario, Canada (Recruiting)
- University of Toronto Odette Cancer Centre - T2 158 Sunnybrook Health Sciences Ccenter — Toronto, Ontario, Canada (Recruiting)
- McGill University Health Centre — Montréal, Quebec, Canada (Recruiting)
- Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden — Dresden, Sachsen, Germany (Recruiting)
- National Center for Spinal Disorders and Buda Health Center — Budapest, Hungary (Recruiting)
- Instituto Ortopedico Rizzoli Department of Oncologic and Degenerative Spine Surgery — Bologna, Emilia-Romagna, Italy (Recruiting)
- IRCCS Istituto Ortopedico Galeazzi Centro die Chirurgia Ortopedica Oncologica e Ricostr — Milano, Lombardei, Italy (Recruiting)
- Kanazawa Medical University Hospital Department of Orthopaedic Surgery — Uchinoda, Ishikawa, Japan (Recruiting)
- Universitair Medisch Centrum Utrecht — Utrecht, Netherlands (Recruiting)
- National University of Singapore Department of Orthopaedic Surgery — Singapore, Singapore (Recruiting)
- Universitätsspital Basel Wirbelsäulenzentrum — Basel, Switzerland (Recruiting)
Study contacts
- Principal investigator: Charles G. Fisher, MD — Vancouver General Hospital and the University of British Columbia
- Study coordinator: Benjamin Bretzinger
- Email: benjamin.bretzinger@aofoundation.org
- Phone: +41 79 814 01 48
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.